Your browser doesn't support javascript.
loading
Motivation for participating in phase 1 vaccine trials: Comparison of an influenza and an Ebola randomized controlled trial.
Cattapan, A; Browne, K; Halperin, D M; Di Castri, A; Fullsack, P; Graham, J; Langley, J M; Taylor, B A; McNeil, S A; Halperin, S A.
Afiliação
  • Cattapan A; Novel Tech Ethics, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada; Johnson Shoyama Graduate School of Public Policy, University of Saskatchewan, Saskatoon, Saskatchewan, Canada. Electronic address: alana.cattapan@usask.ca.
  • Browne K; Novel Tech Ethics, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada; Department of Philosophy, Langara College, Vancouver, British Columbia, Canada.
  • Halperin DM; School of Nursing, St. Francis Xavier University, Antigonish, Nova Scotia, Canada; Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and the Nova Scotia Health Authority, Halifax, Nova Scotia, Canada; Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canad
  • Di Castri A; Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and the Nova Scotia Health Authority, Halifax, Nova Scotia, Canada.
  • Fullsack P; Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and the Nova Scotia Health Authority, Halifax, Nova Scotia, Canada.
  • Graham J; Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and the Nova Scotia Health Authority, Halifax, Nova Scotia, Canada; Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Langley JM; Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and the Nova Scotia Health Authority, Halifax, Nova Scotia, Canada; Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Taylor BA; Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and the Nova Scotia Health Authority, Halifax, Nova Scotia, Canada; Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada; School of Nursing, Dalhousie University, Halifax, Nova Scotia, Canada.
  • McNeil SA; Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and the Nova Scotia Health Authority, Halifax, Nova Scotia, Canada; Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Halperin SA; Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and the Nova Scotia Health Authority, Halifax, Nova Scotia, Canada; Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada.
Vaccine ; 37(2): 289-295, 2019 01 07.
Article em En | MEDLINE | ID: mdl-30528592
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Participação do Paciente / Vacinas contra Influenza / Vacinas contra Ebola / Voluntários Saudáveis / Motivação Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies / Qualitative_research Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País como assunto: America do norte Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Participação do Paciente / Vacinas contra Influenza / Vacinas contra Ebola / Voluntários Saudáveis / Motivação Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies / Qualitative_research Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País como assunto: America do norte Idioma: En Ano de publicação: 2019 Tipo de documento: Article